Chapters

Transcript

Video

Based on the Phase 3 trial of crinecerfont in pediatric CAH—the CAHtalyst Trial—which patients are most likely suitable candidates for treatment with this novel therapey?

Based on the Phase 3 trial of crinecerfont in pediatric CAH—the CAHtalyst Trial—which patients are most likely suitable candidates for treatment with this novel therapey?


Created by

CMEducation Resources | iQ&A Congenital Adrenal Hyperplasia (CAH) Medical Intelligence Zone 

Presenter

Perrin White, MD

Perrin White, MD

Chief, Division of Pediatric Endocrinology
Audre Newman Rapoport Distinguished Chair in Pediatric Endocrinology
UT Southwestern Medical Center
Dallas, TX